Noonberg Sarah B.

CIK 00017063015 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001706301

Recent Transactions

35 trades

Award
Neurogene Inc.$NGNE
Non-Qualified Stock Option (right to buy)
2025-06-12+12,050→ 12,050 total
Sale
Metagenomi, Inc.$MGX
Common Stock
2025-06-06$1.75/sh−5,239→ 109,135 total
Award
Metagenomi, Inc.$MGX
Stock Option (Right to Buy)
2025-04-01+84,000→ 84,000 total
Award
Metagenomi, Inc.$MGX
Common Stock
2025-04-01+14,000→ 114,374 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2024-06-18+10,450→ 10,450 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2024-06-18+2,300→ 14,100 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2024-06-14+7,700→ 7,700 total
Award
Metagenomi, Inc.$MGX
Stock Option (Right to Buy)
2024-04-01+242,875→ 242,875 total
Award
Metagenomi, Inc.$MGX
Common Stock
2024-04-01+57,763→ 100,374 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2024-01-18+4,600→ 11,800 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2024-01-18+20,900→ 20,900 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2024-01-16+15,400→ 15,400 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2023-06-08+25,000→ 25,000 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2023-05-16+7,200→ 7,200 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2023-05-16+32,400→ 32,400 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-01-16+30,000→ 30,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2022-05-12+25,000→ 25,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2021-05-11+25,000→ 25,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2021-02-11$6.98/sh+3,700→ 3,700 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-02-11−3,700→ 3,600 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2021-02-11$25.09/sh−3,700→ 0 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2021-02-10$26.04/sh−400→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-02-10−4,700→ 7,300 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2021-02-10$25.42/sh−4,300→ 400 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2021-02-10$6.98/sh+4,700→ 4,700 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2020-05-28+15,000→ 15,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2020-05-05+25,000→ 25,000 total
Award
Neurogene Inc.$NGNE
Stock Option (right to buy)
2019-10-10+22,000→ 22,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-06-07+12,000→ 12,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-05-29+12,000→ 12,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2017-12-15+24,000→ 24,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2017-12-15+24,000→ 24,000 total
Award
PROTHENA CORP PUBLIC LTD CO$PRTA
Stock Option (right to buy)
2017-05-16+100,000→ 100,000 total

Noonberg Sarah B.

Recent Transactions

Companies

Recent Filings

Address